Claudio Bassi
University of Verona
704 Papers
4.3K Citations
Claudio Bassi is an academic researcher from University of Verona. The author has contributed to research in topics: Medicine & Pancreatic cancer. The author has an hindex of 99, co-authored 637 publications. Previous affiliations of Claudio Bassi include Heidelberg University & University of Texas MD Anderson Cancer Center.
Chat about Author
Papers
Current Definition of and Controversial Issues Regarding Postoperative Pancreatic Fistulas.
TL;DR: Further efforts will be required to better stratify grade B POPFs to standardize treatment strategies and compare outcomes among institutions, and recode grade C POPFs, which now have clearer boundaries, toward the worst end of the severity scale.
37
Pancreaticoduodenectomy for pancreatic cancer: the Verona experience.
Giuseppe Malleo,Giovanni Marchegiani,Roberto Salvia,Giovanni Butturini,Paolo Pederzoli,Claudio Bassi +5 more
TL;DR: This review discusses this center’s experience in surgical treatment of pancreatic head cancer and the preliminary results of radiofrequency thermal ablation of locally advanced ductal cancer are presented.
37
•Journal Article
Cytoreductive surgery in advanced endocrine tumours of the pancreas.
Paolo Pederzoli,Massimo Falconi,Antonio Bonora,Roberto Salvia,Nora Sartori,C. Contro,Stefano Marcucci,Claudio Bassi +7 more
TL;DR: The rationale of this approach is to leave only a liver with residual disease, with a view to giving targeted adjuvant treatment.
37
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration.
Giuseppe Malleo,Laura Maggino,Giovanni Marchegiani,Giovanni Feriani,Alessandro Esposito,Luca Landoni,Luca Casetti,Salvatore Paiella,Elda Baggio,Giovanni Lipari,Paola Capelli,Aldo Scarpa,Claudio Bassi,Roberto Salvia +13 more
TL;DR: Morbidity and mortality rates of Pancreatic head adenocarcinoma with histologically confirmed SMV-PV infiltration does not segregate prognostically from other pT3 tumors and is comparable with standard pancreatectomy.
37
Intraductal papillary mucinous neoplasms (IPMNs): is it time to (sometimes) spare the knife?
TL;DR: The incidence of IPMNs has increased dramatically over the past 10 years and, nowadays, they represent the second indication for pancreatic resection at this institution, after ductal adenocarcinoma.
36